Skip to main
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 11%
Sell 11%
Strong Sell 0%

Bulls say

CareTrust REIT Inc has significantly expanded its structured finance portfolio from $15 million at the beginning of 2022 to $871 million, enhancing operator relationships and diversifying yield within its investment strategy. This growth has contributed to the company achieving an industry-best funds from operations (FFO) growth rate while maintaining the lowest leverage profile among its peers, positioning it strongly in the healthcare real estate sector. Furthermore, analysts project a promising outlook with anticipated embedded funds available for distribution (FAD) growth of 10% by 2026, driven by continued accretive acquisitions and favorable market dynamics in the seniors housing operating properties (SHOP) segment.

Bears say

The analysis indicates a negative outlook on CareTrust REIT's stock due to potential increases in property prices driven by rising competition, which could adversely impact profitability. Additionally, the company faces risks associated with capital market conditions that may result in increased illiquidity, negatively affecting cash investments and asset valuations. Furthermore, the initial lease yield of 8.1% is considered low when compared to industry peers in the US, raising concerns about attracting investment in a market characterized by significant tax leakage and the potential for tenant disruptions affecting earnings growth.

CareTrust REIT (CTRE) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 11% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 9 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $39.78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $39.78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.